Nuclear / MolecularNewsBrief

Emerging PET/CT Radiopharmaceutical May Double Liver Foci Detection

Diagnostic ImagingJul 4

An emerging PET/CT radiopharmaceutical may double the detection of liver foci in patients with neuroendocrine tumors.

Read the source

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.